<DOC>
	<DOC>NCT01446523</DOC>
	<brief_summary>The purpose of this study is to examine S.endotoxins , inflammatory mediators and Magnetic Resonance Spectroscopy (MRS) before and after treatment in patients of cirrhosis and minimal hepatic encephalopathy.</brief_summary>
	<brief_title>S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE</brief_title>
	<detailed_description>60 patients of cirrhosis with Minimal Hepatic Encephalopathy (MHE) who fulfills the inclusion &amp; exclusion criteria will be the part of study. Study patients will be divided in to two groups ( n=30 in each group). Group L patients will receive lactulose therapy while Group NL will receive placebo. After 3 months , S.endotoxins , inflammatory mediators and MRS will be repeated in each group.</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<criteria>Clinical diagnosis of Cirrhosis (Age 15 yr 70 yr ) Recent history of gastrointestinal bleed in last 6 weeks Active ongoing infection Creatinine &gt;1.5mg% Electrolyte impairment. (S. Sodium &lt; 130 meq/L, S. Potassium 3.5 meq/L or &gt;5.0meq/L) H/O use of psychotropic drugs in last 6 weeks Recent alcohol use (&lt; 6 week ) H/O TIPS or shunt surgery. Hepatocellular Carcinoma Severe comorbidity as Congestive Heart Failure, Pulmonary disease, Neurological and Psychiatric problems impairing quality of life Poor vision precluding neuropsychological assessment</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>endotoxins HE</keyword>
</DOC>